Imetelstat (rytelo™) is a telomerase inhibitor.. In june 2024, imetelstat (rytelo™) became the first telomerase inhibitor approved by the u.s food and drug administration (fda).
How to take imetelstat imetelstat is given intravenously (into a vein).. Most cancers and neoplastic progenitor cells have elevated telomerase activity and preservation of telomeres that promote cellular immortality, making telomerase a rational target for.